11Nov
COVID-19 Report for Life Sciences and Health Care Companies (UPDATED)
In Tuesday's Report: the expanding role of real-world evidence in FDA medical device submissions; President-elect Joe Biden lays out COVID-19 plan; Pfizer announces vaccine efficacy; and an analysis of material adverse change (MAC) clauses in Japan....
By:
Hogan Lovells
Related
A controversial California law that would have prevented employers from requiring arbitration agreem...
Read More >
In Logan v. MGM Grand Detroit Casino, released September 25, 2019, the United States Court of Appeal...
Read More >
On Nov. 21, the Queen Mary University of London School of International Arbitration, in partnership ...
Read More >
New Jersey continues to become one of the country’s most employee-friendly states. On January 21, ...
Read More >
The global communications firm Edelman published their annual Edelman Trust Barometer in January. As...
Read More >
Agency Commends Employer for Working Cooperatively With the EEOC on Harassment Prevention and Accoun...
Read More >